Merck, Inc.
🇵🇭Philippines
A Pharmacokinetic Evaluation Study in Healthy Volunteers
Phase 1
Completed
- Conditions
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2015-10-16
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Target Recruit Count
- 12
- Registration Number
- NCT00210093
Instrument Utility for Suspected Asthma (0000-042)(COMPLETED)
Not Applicable
Completed
- Conditions
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2015-01-05
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Target Recruit Count
- 400
- Registration Number
- NCT00211575
A Study to Diagnose Lung Cancer by Sputum Cytology (01-312)
Phase 3
Completed
- Conditions
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2015-09-04
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Target Recruit Count
- 700
- Registration Number
- NCT00210080
A Study to Determine the Efficacy and Safety of 2 Doses of Org 34517 as Adjunctive Therapy in Subjects With Psychotic Major Depression (28130)(P05845)
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2015-11-26
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Target Recruit Count
- 273
- Registration Number
- NCT00212797
A Pharmacokinetic Evaluation Study in Healthy Volunteers
Phase 1
Completed
- Conditions
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2015-10-12
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Target Recruit Count
- 4
- Registration Number
- NCT00210054
A Study in Subjects With Retinal Detachment
Phase 1
Completed
- Conditions
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2015-10-09
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Target Recruit Count
- 14
- Registration Number
- NCT00210067
Study of Chemotherapy and Patient Health Outcomes for Nausea and Emesis (0000-041)
Not Applicable
Completed
- Conditions
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2015-05-01
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Target Recruit Count
- 1500
- Registration Number
- NCT00211601
Sisomicin Cream Vs Nadifloxacin Cream in Primary Pyodermas (Study P04460)
Phase 4
Withdrawn
- Conditions
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2015-06-03
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Registration Number
- NCT00202891
A Placebo-Controlled, Double-Blinded, Randomized Trial of Remicade in Korean Patients With Rheumatoid Arthritis Despite Methotrexate (Study P04280)(COMPLETED)
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2017-03-24
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Target Recruit Count
- 143
- Registration Number
- NCT00202852
Evaluation of Low Dose Infliximab in Ankylosing Spondylitis (Study P04352)
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2017-03-24
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Target Recruit Count
- 76
- Registration Number
- NCT00202865
© Copyright 2024. All Rights Reserved by MedPath